Product name | Semaglutide | ||
Synonyms | Semaglutide powder | ||
Appearance | White powder | CAS # | 910463-68-2 |
Purity | 99% HPLC | M.F. | C187H291N45O59 |
Total Heavy Metals | ≤10ppm | Loss on Drying | ≤ 5% |
Mesh size | 95% pass 80 mesh | Sheliflife | 2 Years |
The primary function of Semaglutide is to help regulate blood sugar levels in people with type 2 diabetes mellitus. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the effects of the hormone GLP-1 in the body. GLP-1 helps to regulate blood sugar levels by reducing the production of glucose in the liver.
Semaglutide is administered as a subcutaneous injection and is typically taken once a week. It has been shown to be effective in reducing blood sugar levels in people with type 2 diabetes, and it may also help to promote weight loss.
In addition to its primary use in the treatment of type 2 diabetes, Semaglutide has also been studied as a potential treatment for other conditions, such as obesity and non-alcoholic steatohepatitis (NASH), a condition in which there is inflammation and damage to the liver due to a buildup of fat.
Semaglutide is generally well-tolerated, but it can have side effects, including nausea, vomiting, and diarrhea. It is important to use Semaglutide only under the guidance of a healthcare professional, and to follow all instructions carefully to minimize the risk of side effects or complications.
For Solid Product | For Liquid Product |
![]() |
![]() |
Weight Range | Transportation Method |
0.1~50 kg | Fedex, DHL, UPS, TNT, EMS |
20~500 kg | By Air |
> 500 kg | By Sea |